SLNO
Soleno Therapeutics Inc

8,230
Mkt Cap
$2.05B
Volume
1.76M
52W High
$90.32
52W Low
$32.63
PE Ratio
178.02
SLNO Fundamentals
Price
$39.68
Prev Close
$38.57
Open
$38.09
50D MA
$42.00
Beta
0.84
Avg. Volume
1.49M
EPS (Annual)
$0.3909
P/B
4.61
Rev/Employee
$1.05M
$2,172.50
Loading...
Loading...
News
all
press releases
INVESTOR ALERT: Soleno Therapeutics Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law
INVESTOR ALERT: Soleno Therapeutics Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit - RGRD Law INVESTOR ALERT: Soleno Therapeutics Inc. Investors with Substantial...
PR Newswire·6h ago
News Placeholder
More News
News Placeholder
Investor Notice: Robbins LLP Informs Investors of the Soleno Therapeutics, Inc. Class Action Lawsuit
Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Soleno Therapeutics (NASDAQ: SLNO) common stock between March 26, 2025...
Business Wire·22h ago
News Placeholder
Royce & Associates LP Trims Stock Holdings in Soleno Therapeutics, Inc. $SLNO
Royce & Associates LP lowered its holdings in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 69.2% during the 3rd quarter, according to the company in its most recent disclosure with the...
MarketBeat·2d ago
News Placeholder
HC Wainwright Lowers Soleno Therapeutics (NASDAQ:SLNO) Price Target to $100.00
HC Wainwright lowered their price target on shares of Soleno Therapeutics from $120.00 to $100.00 and set a "buy" rating for the company in a report on Wednesday...
MarketBeat·3d ago
News Placeholder
Vanguard Group Inc. Purchases 319,317 Shares of Soleno Therapeutics, Inc. $SLNO
Vanguard Group Inc. boosted its position in shares of Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 12.8% during the 3rd quarter, according to its most recent 13F filing with the...
MarketBeat·4d ago
News Placeholder
Rafferty Asset Management LLC Purchases 45,076 Shares of Soleno Therapeutics, Inc. $SLNO
Rafferty Asset Management LLC raised its position in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 95.1% during the third quarter, according to its most recent filing with the Securities...
MarketBeat·5d ago
News Placeholder
Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Up - Still a Buy?
Soleno Therapeutics (NASDAQ:SLNO) Shares Gap Up - What's Next...
MarketBeat·5d ago
News Placeholder
Q1 EPS Forecast for Soleno Therapeutics Raised by Analyst
Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) - Analysts at Lifesci Capital boosted their Q1 2026 EPS estimates for Soleno Therapeutics in a research note issued to investors on Thursday...
MarketBeat·6d ago
News Placeholder
JPMorgan Chase & Co. Buys 140,779 Shares of Soleno Therapeutics, Inc. $SLNO
JPMorgan Chase & Co. grew its stake in Soleno Therapeutics, Inc. (NASDAQ:SLNO - Free Report) by 52.8% during the third quarter, according to its most recent 13F filing with the Securities and...
MarketBeat·7d ago
News Placeholder
Soleno Therapeutics (NASDAQ:SLNO) Downgraded to Hold Rating by Wall Street Zen
Wall Street Zen downgraded Soleno Therapeutics from a "buy" rating to a "hold" rating in a report on Saturday...
MarketBeat·8d ago
<
1
2
...
>

Latest SLNO News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.